Format
Sort by

Send to

Choose Destination

Search results

Items: 13

1.

Haemodynamic and functional consequences of the iatrogenic atrial septal defect following Mitraclip therapy.

Hart EA, Zwart K, Teske AJ, Voskuil M, Stella PR, Chamuleau SA, Kraaijeveld AO.

Neth Heart J. 2016 Nov 28. [Epub ahead of print] Review.

PMID:
27896596
2.

Ultrasound-accelerated Thrombolysis in a Sub-massive Pulmonary Embolism.

Rodríguez-Olivares R, Kraaijeveld AO, Stella PR.

Rev Esp Cardiol (Engl Ed). 2017 Jan;70(1):53. doi: 10.1016/j.rec.2016.04.004. English, Spanish. No abstract available.

PMID:
27198126
3.

Quaking promotes monocyte differentiation into pro-atherogenic macrophages by controlling pre-mRNA splicing and gene expression.

de Bruin RG, Shiue L, Prins J, de Boer HC, Singh A, Fagg WS, van Gils JM, Duijs JM, Katzman S, Kraaijeveld AO, Böhringer S, Leung WY, Kielbasa SM, Donahue JP, van der Zande PH, Sijbom R, van Alem CM, Bot I, van Kooten C, Jukema JW, Van Esch H, Rabelink TJ, Kazan H, Biessen EA, Ares M Jr, van Zonneveld AJ, van der Veer EP.

Nat Commun. 2016 Mar 31;7:10846. doi: 10.1038/ncomms10846.

4.

Quaking, an RNA-binding protein, is a critical regulator of vascular smooth muscle cell phenotype.

van der Veer EP, de Bruin RG, Kraaijeveld AO, de Vries MR, Bot I, Pera T, Segers FM, Trompet S, van Gils JM, Roeten MK, Beckers CM, van Santbrink PJ, Janssen A, van Solingen C, Swildens J, de Boer HC, Peters EA, Bijkerk R, Rousch M, Doop M, Kuiper J, Schalij MJ, van der Wal AC, Richard S, van Berkel TJ, Pickering JG, Hiemstra PS, Goumans MJ, Rabelink TJ, de Vries AA, Quax PH, Jukema JW, Biessen EA, van Zonneveld AJ.

Circ Res. 2013 Oct 12;113(9):1065-75. doi: 10.1161/CIRCRESAHA.113.301302.

5.

Coronary vasospasm induced by painful compression of the brachial artery following coronary angiography.

Kraaijeveld AO, van der Heijden DJ, Sieders A, Kirchhof CJ.

Neth Heart J. 2013 Sep;21(9):417-9. doi: 10.1007/s12471-013-0424-9.

6.

Leukocyte-specific CCL3 deficiency inhibits atherosclerotic lesion development by affecting neutrophil accumulation.

de Jager SC, Bot I, Kraaijeveld AO, Korporaal SJ, Bot M, van Santbrink PJ, van Berkel TJ, Kuiper J, Biessen EA.

Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):e75-83. doi: 10.1161/ATVBAHA.112.300857.

7.

Chemokines CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes.

de Jager SC, Bongaerts BW, Weber M, Kraaijeveld AO, Rousch M, Dimmeler S, van Dieijen-Visser MP, Cleutjens KB, Nelemans PJ, van Berkel TJ, Biessen EA.

PLoS One. 2012;7(9):e45804. doi: 10.1371/journal.pone.0045804.

8.

Chemokines as therapeutic targets for atherosclerotic plaque destabilization and rupture.

Daissormont IT, Kraaijeveld AO, Biessen EA.

Future Cardiol. 2009 May;5(3):273-84. doi: 10.2217/fca.09.4. Review.

PMID:
19450053
9.

Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosis.

de Nooijer R, Bot I, von der Thüsen JH, Leeuwenburgh MA, Overkleeft HS, Kraaijeveld AO, Dorland R, van Santbrink PJ, van Heiningen SH, Westra MM, Kovanen PT, Jukema JW, van der Wall EE, van Berkel TJ, Shi GP, Biessen EA.

Arterioscler Thromb Vasc Biol. 2009 Feb;29(2):188-94. doi: 10.1161/ATVBAHA.108.181578.

10.

Reduced leucocyte cholesteryl ester transfer protein expression in acute coronary syndromes.

Ye D, Kraaijeveld AO, Grauss RW, Willems SM, van Vark-van der Zee LC, de Jager SC, Jauhiainen M, Kuivenhoven JA, Dallinga-Thie GM, Atsma DE, Hogendoorn PC, Biessen EA, Van Berkel TJ, Jukema JW, van Eck M.

J Intern Med. 2008 Dec;264(6):571-85. doi: 10.1111/j.1365-2796.2008.01997.x.

11.

CCL3 (MIP-1 alpha) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events.

de Jager SC, Kraaijeveld AO, Grauss RW, de Jager W, Liem SS, van der Hoeven BL, Prakken BJ, Putter H, van Berkel TJ, Atsma DE, Schalij MJ, Jukema JW, Biessen EA.

J Mol Cell Cardiol. 2008 Sep;45(3):446-52. doi: 10.1016/j.yjmcc.2008.06.003.

PMID:
18619972
12.

CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms.

Kraaijeveld AO, de Jager SC, de Jager WJ, Prakken BJ, McColl SR, Haspels I, Putter H, van Berkel TJ, Nagelkerken L, Jukema JW, Biessen EA.

Circulation. 2007 Oct 23;116(17):1931-41.

13.

Chemokines and atherosclerotic plaque progression: towards therapeutic targeting?

Kraaijeveld AO, de Jager SC, van Berkel TJ, Biessen EA, Jukema JW.

Curr Pharm Des. 2007;13(10):1039-52. Review.

PMID:
17430167
Items per page

Supplemental Content

Loading ...
Support Center